Quest Diagnostics To Buy Outreach Lab Service In Cape Cod
Zacks Investment Research | Jun 27, 2017 10:59PM ET
Quest Diagnostics Inc. (NYSE:DGX) , a leading diagnostic testing information service provider is on track with its mergers and acquisitions (M&A) strategy. In keeping with this strategy, the company has recently teamed up with Cape Cod Healthcare (CCHC) to obtain its outreach laboratory service business.
Although the financial terms of the purchase agreement were not disclosed, yet Quest Diagnostics expects to close the deal by Jan 1, 2018, subject to negotiation of definitive agreements related to transaction as well as customary closing conditions.
Notably, CCHC provides healthcare services to residents and visitors in Cape Cod. As an outreach laboratory services provider, it delivers local physicians and patients’ — inpatient or outpatient care — which is separate from a hospital treatment.
Per the acquisition deal, post termination of this transaction, the diagnostic testing information centre would convert into a full-service, state-of-the-art clinical laboratory for Quest Diagnostics in Marlborough, Mass. Notably, CCHC’s hospital-based laboratories and the inpatient-outpatient services are not included in the transaction.
Post closure of this acquisition, the outreach laboratory service business of CCHC is expected to deliver Quest Diagnostics’ patient access and convenient laboratory services in this location. Per the company, this is feasible by leveraging on CCHC’s huge patient service center network in Cape Cod and a number of clinical laboratory tests, including advanced genetic sequencing tests for cancer, neurological disorders plus other diseases.
The transaction is estimated to be a strategic fit as it would benefit from Quest Diagnostics’ scale and expertise to produce more cost-effective testing facilities for patients as well as government and commercial health plans.
Quest Diagnostics’ merger and acquisition activity is believed to be a key growth driver, functioning in full swing. Worth noting is the company’s recent contract to acquire an outreach operation of PeaceHealth Laboratories, anticipated to close in second quarter. Post the closing, the company is set to execute a professional laboratory services agreement to manage 11 PeaceHealth Laboratories, serving medical centers across three states in Pacific Northwest zone. This move is likely to bolster growth, later in 2017.
Per the company, these tuck-in acquisitions fit well within its M&A guidelines. The takeover plans of Quest Diagnostics are consistent with the company’s goal of contributing 1–2% revenue growth annually via accretive acquisitions.
Price Performance
Get The News You Want
Quest Diagnostics has significantly outperformed the Zacks categorized Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.